Exchange: NYSE
Industry: Drug Manufacturers/Major
Last Trade: 4:01 PM ET 2/8/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.13 | 1.03 | 9.71 |
| EPS, GAAP | 0.09 | 0.70 | -87.14 |
| Consensus Estimate | 1.10 | 1.03 | 6.80 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 5.00 | 5.00 | 0.00 |
| EPS, GAAP | 4.10 | 3.16 | 29.75 |
| Consensus Estimate | 4.80 | NA | NA |
| JNJ | Industry Average | |
| P/E (TTM) | 15.91 | 17.80 |
| P/E (Forward) | 12.77 | 13.00 |
| PEG Ratio | 2.17 | 2.45 |
| Price/Sales | 2.81 | 2.54 |
| Beta | 0.54 | 0.56 |
| 1:02 PM | 2/3/2012 | Venezuela's Business Sector Awaits Word On New Price Caps |
| 4:38 PM | 2/2/2012 | 4th UPDATE: Merck Swings To 4Q Profit; Sales Up 4% |
| 2/8/2012 | Treasurers Bristle at Money Market Proposals (WSJ.com) |
| 2/8/2012 | Oakmark's Nygren: BAC On Right Course; Favors MRK, BMY Vs. JNJ (Barrons.com) |
| 2/8/2012 | My 3 Favorite Dividend Payers (The Motley Fool) |
| 2/7/2012 | Big U.S. Firms Sidestep Euro-Crisis Damage (WSJ.com) |
| 2/7/2012 | Glaxo Slips After Disappointing Earnings, Diabetes Drug Sales (Barrons.com) |
| 2/7/2012 | Low-volatility stocks are useful but not sufficient for a strong portfolio. (The Motley Fool) |
| 2/4/2012 | A Market List for Seekers of Calm (Barrons.com) |
| 2/3/2012 | Bank of America relents on Dendreon. (The Motley Fool) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
